The 2007-2012 Outlook for Oral Drug Delivery Systems in the United States

Icon Group International, Inc.
November 1, 2006
703 Pages - SKU: ICN1734473
Attention: There is an updated edition available for this report.
Countries covered: United States

This study covers the latent demand outlook for oral drug delivery systems across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 13,000 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and city, latent demand estimates are created for oral drug delivery systems. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the cities in the United States). This study gives, however, my estimates for the latent demand, or the P.I.E., for oral drug delivery systems in the United States. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of the United States. For each state, I also show my estimates of how the P.I.E. grows over time. In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on strategic planning at graduate schools of business.



More Drug Delivery reports by Icon Group International, Inc.

The 2013-2018 Outlook for Pulmonary Drug Delivery Technologies in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Pulmonary Drug Delivery Technologies in the United StatesThis econometric study covers the latent demand outlook for pulmonary drug delivery technologies across ...
The 2013-2018 Outlook for Intranasal Drug Delivery Applications in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Intranasal Drug Delivery Applications in the United StatesThis econometric study covers the latent demand outlook for intranasal drug delivery applications across ...
The 2013-2018 World Outlook for Pulmonary Drug Delivery Technologies by Icon Group International, Inc.
The 2013-2018 World Outlook for Pulmonary Drug Delivery TechnologiesThis econometric study covers the world outlook for pulmonary drug delivery technologies across more than 200 countries. ...
The 2013-2018 World Outlook for Intranasal Drug Delivery Applications by Icon Group International, Inc.
The 2013-2018 World Outlook for Intranasal Drug Delivery ApplicationsThis econometric study covers the world outlook for intranasal drug delivery applications across more than 200 countries. ...
See all reports like this >>

More United States Drug Delivery reports

U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2014 by iData Research, Inc.
Abstract:According to the Center for Disease Control and Prevention (CDC), diabetes is the seventh leading cause of death among Americans as of 2014. Moreover, diagnosed ...
The 2013-2018 Outlook for Pulmonary Drug Delivery Technologies in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Pulmonary Drug Delivery Technologies in the United StatesThis econometric study covers the latent demand outlook for pulmonary drug delivery technologies across ...
The 2013-2018 Outlook for Intranasal Drug Delivery Applications in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Intranasal Drug Delivery Applications in the United StatesThis econometric study covers the latent demand outlook for intranasal drug delivery applications across ...
Nanotechnology Drug Delivery Market in the US 2012-2016 by TechNavio - Infiniti Research Ltd.
TechNavio's analysts forecast the Nanotechnology Drug Delivery market in the US to grow at a CAGR of 84.79 percent over the period 2012-2016. One of ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 495  
    Global Site License  USD 990  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!